Article
Fragile X syndrome: from targets to treatments.
Neuropharmacology - 1 May 2013
Wijetunge Lasani S, Chattarji Sumantra, Wyllie David J A, Kind Peter C
Abstract excerpt
Fragile X syndrome (FXS) is one of the most prevalent and well-studied monogenetic causes of intellectual disability and autism and, although rare, its high penetrance makes it a desirable model for the study of neurodevelopmental disorders more generally. Indeed recent studies suggest that there is functional convergence of a number of genes that are implicated in intellectual disability and autism indicating...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
